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Abstract
Objectives:  To examine the association between time of smoking initiation and both the
independent and joint effects of active and passive tobacco smoke exposure and the risk of breast
cancer in a sample of Ontario women.
Methods: Data from two large population-based case-control studies conducted among Ontario
women aged 25–75 years were combined for analysis (n = 12,768).
Results: Women who had ever smoked and were exposed to passive smoke had a significant
increased risk of breast cancer (OR 1.13, 95%CI 1.01–1.25). A significant increased risk was also
observed among women who initiated smoking: at age 26 or older (OR 1.26, 95%CI 1.03–1.55);
more than five years from menarche (OR 1.26, 95%CI 1.12–1.42); and, after their first live birth
(OR 1.25, 95%CI 1.02–1.52).
Conclusion: The results suggest that women who initiate smoking at an older age are at an
increased risk of breast cancer.
Introduction
Smoking is the largest preventable cause of cancer [1], yet
smoking rates among women remain high. In 2007,
18.1% of Canadian women aged 15 and older were cur-
rent smokers [2], with young adult females aged 20–24
exhibiting the highest prevalence of use (25.6%). Consid-
ering that declines in the prevalence of smoking among
young adult females have reached a plateau [2], and older
ages of smoking onset among young adult women is an
emerging trend [3], it appears that smoking will continue
to represent a considerable public health burden among
Canadian women.
Breast cancer, the most common cancer in Canadian
women excluding non-melanoma skin cancer, is a leading
cause of cancer-related morbidity and mortality in Can-
ada [4]. There is some evidence of a link between tobacco
smoke exposure and breast cancer [e.g., [1,5-16]]. Animal
models have demonstrated that mammary tissue may
have increased susceptibility to carcinogenic exposures
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during the years from pre-puberty to age at first full-term
pregnancy [17,18]. The breast experiences its highest rate
of cellular proliferation during this period and there may
be a decreased ability of DNA repair mechanisms to cor-
rect damage before cell division occurs [6]. This is consist-
ent with the hypothesis that cigarette smoke, either active
or passive, in this age period increases the risk of breast
cancer in women. However, the majority of studies over
the past few decades examining smoking during this age
period have produced inconsistent results [6-16]. In order
to help clarify this relationship, we examined the associa-
tion between breast cancer and active and passive smok-
ing both independently and jointly in a combined data set
of two case-control studies conducted in Ontario.
Methods
Data from the Ontario Women's Health Study (OWHS)
(conducted between June 1996 and May 1998 among
6195 women aged 25 to 75 years [19]), and the Ontario
Women's Diet and Health Study (OWDHS) (conducted
between June 2002 and April 2003 among 6573 women
aged 25 to 75 years [20]) were combined for this second-
ary analysis. The OWDHS and OWHS are large popula-
tion based-based-case-control studies. Both had similar
target populations, data collection methodologies, and
measures. Ethics approval was granted by the University
of Toronto Research Ethics Board [19,20].
Cases
Women age 25–74 years and who were diagnosed with a
first, pathologically confirmed cancer of the breast were
identified in both studies through the Ontario Cancer
Registry (OCR). The OCR is a population-based cancer
registry and includes cases of invasive cancer diagnosed
among residents of Ontario [21]. Over 95% of all breast
cancer pathology reports from the hospitals and laborato-
ries in Ontario are received by the OCR, all nearly within
three months of biopsy. Due to the high number of breast
cancer cases diagnosed each year in Ontario (~4400), the
OWHS sampled cases randomly using a 50% sampling
fraction, while the OWDHS selected all cases in an 11-
month period. Pathology reports were used to identify
physicians to obtain consent to contact and contact infor-
mation for the cases. Physician cooperation was high for
both studies, 95% in the OWHS and 96% in the OWDHS.
Physician response was over 90%.
Controls
Controls for both studies were age-stratified random sam-
ples of Ontario women who were 1:1 frequency matched
to cases within five-year age groups. The OWHS identified
controls in the 1996 population-based assessment rolls
database of the Ontario Ministry of Finance (MOF),
which included full name, age, sex, and address for all
homeowners and tenants in Ontario. The OWDHS iden-
tified controls through random digit dialing.
Data collection
Both the OWHS and the OWDHS used self-administered
mailed questionnaires containing questions regarding
known or suspected risk factors for breast cancer includ-
ing various measures of active and passive tobacco smoke
exposures. Both studies made efforts to improve response
by including a five dollar incentive [22], and by sending
non-responders a reminder post-card after two weeks, fol-
lowed by a telephone call after four weeks. The response
rate for the OWHS, after deleting cases for whom physi-
cian consent was not obtained, was 73% (3133 of 4289
women) for cases and 61% (3062 of 5001 women) for
controls. The response rate for the OWDHS was 75%
(3102 of 4109 women) for the cases and 85% (3471 of
4102 eligible women) for the controls. The difference in
the response rate for the controls among the two studies is
attributable to the control selection method in the
OWDHS, where only those women who expressed some
interest in participating in the study when contacted by
random digit dialing were mailed a questionnaire.
Definitions of exposure
Consistent with the Canadian Tobacco Use Monitoring
Survey (2007) [2], ever active smoking was conservatively
defined as having ever smoked at least 100 cigarettes in
their lifetime. Participants were also asked how many
hours in a day they were exposed to the tobacco smoke of
others as a child and approximately two years ago (the lat-
ter for both working and non-working days). Those who
were exposed to less than 2 hours a day on average were
categorized as having no passive smoke exposure and
those who were exposed to 2 or more hours per day in
childhood, adulthood or both were considered to be
exposed to passive smoke. The referent category through-
out the analysis was defined as no history of active or pas-
sive smoking. Although passive smoke exposure and
active smoke exposure were conservatively defined (due
to the limitations of the measures available), using such
conservative estimates biases our results to the null, con-
sequently any significant associations likely represent
meaningful differences across groups.
Statistical analysis
A total of 6235 cases and 6533 controls were available for
this analysis. Women were excluded if they had missing
data for age at menarche (n = 332); the analysis examining
age at smoking initiation in relation to first live birth
included only parous women (n = 11039). Logistic regres-
sion analyses were used to examine the risk of breast can-
cer in relation to smoking exposure, age of initiation,
smoking initiation in relation to menarche, and smokingTobacco Induced Diseases 2009, 5:4 http://www.tobaccoinduceddiseases.com/content/5/1/4
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initiation in relation to first live birth. A category for miss-
ing values for each variable was included in all models
and adjustments were made for the frequency matching
variable age and for other potential confounders: age of
menarche, age of first live birth, parity, BMI, oral contra-
ceptive use, hormone-replacement therapy, alcohol con-
sumption, menopausal status, family history of breast
cancer, history of benign breast disease and household
income. None of the potential confounders changed the
risk estimates by more than 10%; as such, only age-
adjusted odds ratios are presented. All analyses were per-
formed with SAS version 9.1 [23].
Results
Since the distribution of selected subject characteristics
and risk factors for cases and controls were similar across
the two studies (data not shown), the combined descrip-
tive data are presented in Table 1. In general, the distribu-
tions within our sample are consistent with existing
research, in which cases had a significantly increased risk
of breast cancer with use of hormone replacement ther-
apy, family history of breast cancer, history of benign
breast disease, early age of menarche, older age at first
birth, and nullparity [6-16].
The frequency distributions and the age-adjusted odds
ratios for breast cancer in relation to smoking status and
timing of smoking initiation are presented in Table 2.
Notable significant findings include: women who were
active smokers and exposed to passive smoke had
increased risk of breast cancer (OR 1.13, 95%CI 1.01–
1.25) compared to women with no history of active or
passive smoking; there was a monotonic increase in the
risk of breast cancer in relation to increasing age of smok-
ing initiation; women who began smoking at age 26 or
older had increased risk of breast cancer (OR 1.26, 95%CI
1.03–1.55) compared to women with no history of active
or passive smoking; women who initiated smoking more
than 5 years after menarche had increased risk of breast
cancer (OR 1.26, 95%CI 1.12–1.42) compared to women
with no history of active or passive smoking; women who
initiated smoking after their first live birth were at
increased risk for breast cancer (OR 1.25, 95%CI 1.02–
1.52) compared to women with no history of active or
passive smoking; and, women who initiated smoking
more than five years before their first live birth were at
increased risk for breast cancer (OR 1.16, 95%CI 1.04–
1.31) compared to women with no history of active or
passive smoking.
Analyses stratified by age of menarche and by age of first
live birth demonstrated the same risk patterns as seen in
Table 2 (data not shown). Furthermore, as the age cutoff
for early age of menarche was set lower, the odds ratio for
breast cancer risk due to smoking before menarche
increased, although the results were not significant.
Discussion
Consistent with reviews of existing research [1,24-26], we
identified that women living in Ontario exposed to both
active and passive cigarette smoke were at increased risk of
breast cancer when compared to never active and never
passive smokers. We decided to look at passive smoke
exposure in women already exposed to active smoke as
studies have established a difference in the carcinogenic
mechanisms between active and passive smoke exposure
on breast cancer risk [27]. Tobacco specific nitrosamines
and other carcinogens are more concentrated in passive
smoke than mainstream smoke [27]. In addition, in com-
parison to mainstream smoke, a greater proportion of
sidestream smoke is in the vapor phase than in the partic-
ulate phase, which results in greater absorption of chemi-
cals into the blood and lymph systems. Therefore it has
been suggested that exposure to passive smoke can
present a greater risk than active smoke alone [27,28].
This finding may have important implications for cancer
control when one considers that smoking rates among
Ontario women have declined in the past decade [2], and
fewer Ontario women will be exposed to passive smoke
due to the new restrictions associated with the 2006
Ontario Tobacco Strategy which banned smoking in pub-
lic places in Ontario [29]. It may be possible that, even
though breast cancer rates in Ontario are currently on the
rise [4], such population-level reductions in tobacco
smoke exposure (through both active and passive smok-
ing) may have a positive impact on reducing future breast
cancer rates in the province.
Conversely, our data suggest that the risk of breast cancer
monotonically increased with increased age of smoking
initiation. This relationship has been reported in several
case-control studies [6,7,14,15] and one cohort study
[16]. Although the existing evidence is mixed and other
studies have reported an inverse relationship between age
of initiation and breast cancer risk [30], such inconsisten-
cies may be attributed to variations in study design and
differences in measuring smoke exposure. Similarly, with
our conservative estimates we also identified an increased
risk of breast cancer among women who initiated smok-
ing after their first live birth and among women who ini-
tiated smoking more than five years after menarche. These
findings are also consistent with existing studies examin-
ing breast cancer risk and timing of smoking around preg-
nancy [7,12,15,16] and menarche [10,12,14]. Given the
emerging trend of older ages of smoking onset among
women in Canada [3], the relationship between older
ages of smoking onset and breast cancer risk may be cause
for concern and requires additional investigation.Tobacco Induced Diseases 2009, 5:4 http://www.tobaccoinduceddiseases.com/content/5/1/4
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Table 1: Distribution of demographic variables and known breast cancer risk factors among women in the combined studies
Risk Factor Cases
(n = 6065)
Controls
(n = 6371)
No. % No. % Chi-Square
Age
25 – 34 118 1.9 200 3.1 χ2 = 43.21, df = 4, p < .001
35 – 44 807 13.3 1001 15.7
45 – 54 1739 28.7 1868 29.3
55 – 64 1823 30.1 1704 26.8
65 – 75 1578 26.0 1598 25.1
Age at menarche
< 12 1183 19.5 1155 18.1 χ2 = 10.90, df = 2, p < .01
12 – 14 4200 69.3 4389 68.9
15 + 682 11.2 827 13.0
Menopausal status
Pre 1784 29.4 2133 33.5 χ2 = 22.15, df = 3, p < .001
Post 4192 69.1 4184 65.1
Don't Know 85 1.4 84 1.3
Missing 4 0.1 6 0.1
Pregnancy
Never 773 12.7 603 9.5 χ2 = 33.98, df = 2, p < .001
Ever 5282 87.1 5757 90.4
Missing 10 0.2 11 0.2
Age at first live birth
Null parous 773 12.8 603 9.5 χ2 = 62.00, df = 5, p < .001
< 21 1141 18.8 1321 20.7
21 – 24 1545 25.5 1870 29.4
25 – 29 1570 25.9 1612 25.3
30 + 807 13.3 772 12.1
Missing 229 3.8 193 3.0
Number of live births
Null parous 773 12.6 603 9.5 χ2 = 69.84, df = 4, p < .001
1 child 771 12.7 755 11.9
2 children 2197 36.2 2255 35.4
3 + children 2102 34.7 2584 40.6
Missing 222 3.7 174 2.7
Use of oral contraceptives
No 2815 46.4 2825 44.3 χ2 = 11.54, df = 3, p < .01
Yes 3184 52.5 3466 54.4
Don't Know 46 0.8 40 0.6
Missing 20 0.3 40 0.6
Use of hormone replacement therapy
No 3954 65.2 4328 67.9 χ2 = 15.32, df = 3, p < .01
Yes 2048 33.8 1994 31.3
Don't Know 37 0.6 20 0.3
Missing 26 0.4 29 0.5
Family history of breast cancer
No 4692 77.4 5367 84.2 χ2 = 141.53, df = 3, p < .001
Yes 1130 18.6 707 11.1
Don't Know 65 1.1 69 1.1
Missing 178 2.9 228 3.6
Benign breast disease
No 3227 53.2 4688 73.6 χ2 = 565.80, df = 3, p < .001
Yes 2577 42.5 1482 23.3
Don't know 58 1.0 42 0.7
Missing 203 3.3 159 2.5
Body mass index (kg/m2)
< 18.5 91 1.5 110 1.7 χ2 = 8.64, df = 5, p = .124
18.5 – 24.9 2573 42.4 2836 44.5
25 – 29.9 2028 33.4 2091 32.8
30 – 34.9 861 14.2 832 13.1
35+ 435 7.2 425 6.7Tobacco Induced Diseases 2009, 5:4 http://www.tobaccoinduceddiseases.com/content/5/1/4
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Implications for research and practice
Our findings suggest that there is a need to further exam-
ine the impact of population-level shifts in the prevalence
of smoking, exposure to passive tobacco smoke, and
increasing ages of smoking onset among women on future
breast cancer rates. In addition, in 2004, although 89% of
25–34 year old Canadian women reported visiting a doc-
tor, the majority of them reported that they were not
asked about their smoking behaviour, and among those
who were current smokers, only 39% reported being pro-
vided with cessation information from their doctor [31].
Since health professionals can play an important role in
reducing smoking uptake and cessation, a simple popula-
tion-level intervention may involve having doctors sys-
tematically ask young adult female patients about their
smoking behaviour and provide cessation assistance (e.g.,
nicotine replacement therapy) to those smokers who want
to quit, according to clinical practice guidelines. It has
been shown that such smoking cessation interventions are
both successful and cost effective [32].
Missing 77 1.3 77 1.2
Family income adequacy
Low 663 10.9 725 11.4 χ2 = 6.11, df = 4, p = .191
Middle 2033 33.5 2215 34.8
High 2183 36.0 2268 35.6
No answer 1007 16.6 1006 15.8
Missing 179 2.9 157 2.5
Alcohol use (drinks/week)
Never drink 1339 22.1 1358 21.3 χ2 = 17.18, df = 5, p < .01
< 1 1277 21.1 1451 22.8
1 – 3 1796 29.6 1980 31.1
4 – 6 630 10.4 616 9.7
7 + 939 15.5 866 13.6
Missing 84 1.4 100 1.6
Table 1: Distribution of demographic variables and known breast cancer risk factors among women in the combined studies (Continued)
Table 2: Distribution of cases and controls and age-adjusted odds ratios for breast cancer among women in the combined studies in 
relation to smoking status and time of active smoking initiation
Cases
(n = 6065*)
Controls
(n = 6371*)
Risk Factor No. % No. % AOR (95% CI)†
Smoking exposure
Never active/never passive 1270 24.2 1398 25.1 1.0 (ref)
Passive only 1481 28.2 1699 30.5 0.97 (0.88–1.08)
Active only 1143 21.8 1124 20.2 1.10 (0.98–1.23)
Both Active and Passive 1352 25.8 1343 24.1 1.13 (1.01–1.25)
Age of initiation
Never active/never passive smoker 1270 29.2 1398 31.7 1.0 (ref)
< 12 44 1.0 58 1.3 0.88 (0.59–1.31)
12 – 15 759 17.8 848 19.2 1.02 (0.90–1.16)
16 – 20 1586 37.2 1563 35.4 1.12 (1.01–1.24)
21 – 25 369 8.7 350 7.9 1.13 (0.96–1.33)
26 + 235 5.5 195 4.4 1.26 (1.03–1.55)
Initiation in relation to menarche
Never active/never passive smoker 1270 34.0 1368 36.0 1.0 (ref)
Before menarche 216 5.8 283 7.4 0.87 (0.71–1.05)
Initiate ≤ 5 years from menarche 1242 33.2 1290 34.0 1.07 (0.96–1.19)
Initiate > 5 years from menarche 1008 27.0 860 22.6 1.26 (1.12–1.42)
Initiation in relation to first live birth ‡
Never active/never passive smoker 1087 34.5 1231 36.5 1.0 (ref)
Before first birth:
> 5 years before 1132 35.9 1130 33.6 1.16 (1.04–1.31)
≤ 5 years before 677 21.5 788 23.4 0.96 (0.84–1.09)
After first birth 254 8.1 219 6.5 1.24 (1.02–1.52)
* Numbers may not add to total due to missing values
† AOR = age adjusted odds ratio: adjusted only for age since no confounders were identified
‡ Only among parous women (n = 11039)Tobacco Induced Diseases 2009, 5:4 http://www.tobaccoinduceddiseases.com/content/5/1/4
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Limitations
Due to the case-control study design and the use of self-
reported questionnaires, there is a possibility of recall bias
of their active and passive smoking history, however,
research suggests that the impact of recall bias in case-con-
trol studies of smoking and breast cancer is limited
[15,33]. There is also the possibility of misclassification
for the age of smoking initiation, age of menarche and age
of first live birth; however, this is unlikely as smoking is
not a widely perceived risk factor for breast cancer [10],
and certainly not at the time of our data collection. The
measures for active and passive smoking are very conserv-
ative and likely provide estimates of actual exposure
which should bias results to the null. Although more
robust measures of smoking (i.e. intensity, puff volume,
or pack years) would have been useful, we were restricted
due to the limitations of the OWHS and OWDHS ques-
tionnaires used for analysis. Moreover, our subjective self-
report measures of active and passive smoking would be
more robust if validated with objective biochemical anal-
yses of salivary cotinine [34]. At the time these studies
were initiated, passive smoking was not recognized as an
established risk factor for breast cancer; and as a result the
measures used for passive smoke exposure are not as
robust as would be ideal. However, the conservative defi-
nitions do not necessarily negatively affect our findings as
the primary purpose of the study is to examine the risk of
breast cancer among women ever exposed to active and
passive smoke compared to those never exposed.
We were able to control for passive smoke exposure by
including both never active and never passive smokers in
the referent group. Although it is possible those exposed
to passive smoking were included in the unexposed cate-
gory, thereby inadvertently diluting the effects of passive
smoking; studies with more robust exposure measure-
ments that are better able to limit passive smoke exposure
in the referent group tend to demonstrate an even higher
breast cancer risk. Therefore, our conservative estimates
actually underestimate the association between passive
smoke exposure and breast cancer. There were also a large
number of missing values, but these were largely confined
to the referent group as expected (i.e., cases tend to have
higher response rates due to their diagnosis of breast can-
cer) and were approximately equal among the cases and
the controls. The slight differences that did exist are not
likely to bias the estimates since there is no reason to
expect that the non-response was associated with the
exposure of interest (i.e., active and passive smoking).
Conclusion
The population-level shifts in the prevalence of smoking,
exposure to passive tobacco smoke, and increasing ages of
smoking onset among women are likely to have an impact
on breast cancer rates due to the relationship between
breast cancer and active and passive tobacco smoke expo-
sure. As such, practitioners should consider targeting
smoking prevention initiatives not only to female youth,
but also to young adult female populations.
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